JHS Svendgaard Laboratories' Q1 FY 2025-26 Quarterly Results
- 13 Aug 2025
Result Summary
- JHS Svendgaard Laboratories Ltd reported a 6.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 1.4%.
- Its expenses for the quarter were up by 4.2% QoQ and down 3.2% YoY.
- The net profit decreased 241.3% QoQ and decreased 268.3% YoY.
- The earnings per share (EPS) of JHS Svendgaard Laboratories Ltd stood at 0.1 during Q1 FY 2025-26.
Financial Statments for Q1 FY 2025-26
Total Income | 24.45 | 23.04 | 24.80 | 6.1% | -1.4% |
Total Expenses | 23.83 | 22.86 | 24.61 | 4.2% | -3.2% |
Profit Before Tax | 0.63 | 0.18 | 0.20 | 250.0% | 215.0% |
Tax | -0.43 | 0.93 | 0.83 | -146.2% | -151.8% |
Profit After Tax | 1.06 | -0.75 | -0.63 | -241.3% | -268.3% |
Earnings Per Share | 0.10 | -0.10 | -0.10 | -200.0% | -200.0% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
JHS Svendgaard Laboratories Ltd is a company that operates within the consumer goods sector, focusing primarily on oral care products. The company is involved in the manufacturing and distribution of a range of dental hygiene products, including toothbrushes, toothpastes, and other oral care essentials. JHS Svendgaard Laboratories Ltd has established its presence in both domestic and international markets. As of the latest available information, there are no specific recent major developments or announcements disclosed, and further details about the company's strategic directions or operational changes are not readily available based solely on the given data.
Revenue
In Q1FY26, JHS Svendgaard Laboratories Ltd reported a total income of ₹24.45 crores. This represents a quarter-over-quarter (QoQ) increase of 6.1% from Q4FY25, where the total income was ₹23.04 crores. However, compared to the same quarter in the previous year, Q1FY25, there was a slight year-over-year (YoY) decrease of 1.4%, as the total income then was ₹24.80 crores. The data indicates that while there is a positive trend in revenue on a sequential quarterly basis, the company has experienced a minor decline when looking at the yearly comparison.
Profitability
Analyzing the profitability metrics, JHS Svendgaard Laboratories Ltd showed a significant improvement in its profit before tax (PBT) for Q1FY26, reaching ₹0.63 crores, compared to ₹0.18 crores in Q4FY25 and ₹0.20 crores in Q1FY25. This reflects a substantial QoQ growth of 250.0% and a YoY increase of 215.0%. The company’s tax obligations showed a negative value of -₹0.43 crores in Q1FY26, a stark contrast to a positive tax expense of ₹0.93 crores in Q4FY25 and ₹0.83 crores in Q1FY25. Consequently, the profit after tax (PAT) for Q1FY26 was reported at ₹1.06 crores, marking a turnaround from a loss of -₹0.75 crores in Q4FY25 and -₹0.63 crores in Q1FY25.
Operating Metrics
The operating metrics of JHS Svendgaard Laboratories Ltd reveal an increase in total expenses for Q1FY26, amounting to ₹23.83 crores, which is a 4.2% rise from the previous quarter (Q4FY25) where expenses were ₹22.86 crores. On a YoY basis, there is a decrease of 3.2% compared to ₹24.61 crores in Q1FY25. Earnings per share (EPS) for Q1FY26 improved significantly to ₹0.10, compared to negative earnings of -₹0.10 in both Q4FY25 and Q1FY25, indicating a 200.0% increase on both QoQ and YoY comparisons. These metrics highlight a notable recovery in the company’s bottom line performance over the reported periods.